Chemical Compound

2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide; AZD 9291; Osimertinib; Tagrisso

CAS Registry Number 1421373-65-0
返回搜索 申请报价
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide; AZD 9291; Osimertinib; Tagrisso 结构式
Primary record

2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide; AZD 9291; Osimertinib; Tagrisso

库存
6,044 克
纯度
98.5 %
CAS
1421373-65-0

化合物标识与属性

CAS
1421373-65-0
PubChem CID
71496458
SMILES
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
Canonical SMILES
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C

名称与同义词

  • osimertinib
  • Mereletinib
  • AZD-9291
  • 1421373-65-0
  • AZD9291
  • Tagrisso
  • osimertinibum
  • Osimertinib mesylate
  • Osimertinib [USAN]
  • Osimertinib D6
  • Mereletinib [INN]
  • osimertinib mesilate
  • AZD 9291
  • AZD9291 mesylate
  • Osimertinib (Standard)
  • Tube720
  • UNII-3C06JJ0Z2O
  • AZD-9291 mesylate
  • Osimertinib (AZD9291)
  • RefChem:58257
  • OSIMERTINIB [MI]
  • 3C06JJ0Z2O
  • AZD-9291 FREE BASE
  • OSIMERTINIB [INN]
  • MFCD27988062
  • AZD 9291(Osimertinib)
  • D0RT2C
  • Osimertinib; AZD 9291
  • Osimertinib; AZD-9291
  • mereletinib (obsolete INN)
  • C28H33N7O2
  • AZD-9291(Osimertinib)?
  • OSIMERTINIB [WHO-DD]
  • AZ-GHS-22
  • CHEBI:90943
  • DTXSID501025961
  • GTPL7719
  • orb1305406
  • Tyrosine Kinase Inhibitor - Ns
  • CHEMBL3353410
  • SCHEMBL14660911
  • SCHEMBL29350904
  • SCHEMBL29378405
  • AMY9161
  • AOB6268
  • EX-A314
  • L01XE35
  • MereletinibAZD-9291,Osimertinib
  • DUYJMQONPNNFPI-UHFFFAOYSA-N
  • DTXCID401510212
  • GLXC-05459
  • HMS3653E10
  • HMS3672M05
  • HMS5085F14
  • BCP08626
  • KS-000007ZW
  • MSK11040
  • NQC28144
  • TVB02091
  • ABP001123
  • BDBM50029668
  • EBC-07876
  • HY-15772R
  • NSC779217
  • NSC781254
  • NSC800812
  • s7297
  • ZINC98023177
  • AKOS025290756
  • C28-H33-N7-O2
  • ACN-031533
  • CCG-264683
  • CS-2018
  • DB09330
  • FD58317
  • NSC-779217
  • NSC-781254
  • NSC-800812
  • SB22952
  • NCGC00378622-03
  • NCGC00378622-04
  • NCGC00378622-10
  • 4CA-0243
  • AC-29019
  • AK170511
  • AS-16943
  • BP-43647
  • HY-15772
  • QC-11454
  • SC-94470
  • N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
  • N-(2-{[2-(Dimethylamino)ethyl](Methyl)amino}-4-Methoxy-5-{[4-(1-Methyl-1h-Indol-3-Yl)pyrimidin-2-Yl]amino}phenyl)prop-2-Enamide
  • 4714B
  • B1104
  • NS00073136
  • SW219863-1
  • X3507
  • J3.291.102A
  • N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
  • A13681
  • EN300-7382438
  • A854509
  • BRD-K42805893-001-04-9
  • Q21506464
  • 2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-
  • C000603933
  • B0084-462147
  • N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
  • N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide
  • Osimertinib, 98%, a potent and selective mutated forms EGFR inhibitor - 25MG 25mg
  • 1143020-91-0
  • 1638281-44-3
  • 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
  • 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide; AZD 9291; Osimertinib; Tagrisso
  • N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide
  • N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)acrylamide
  • N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide
  • N-(2-(2-(dimethylamino)ethyl-methylamino)-4-methoxy-5-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide
  • N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide
  • N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
  • N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4- (1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide
  • N-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
  • N-[2-[Methyl 2-(dimethylamino)ethylamino]-4-methoxy-5-[4-(1-methyl-1H-indol-3-yl)pyrimidine-2-ylamino]phenyl]acrylamide
  • N-[2-[Methyl[2-(dimethylamino)ethyl]amino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]acrylamide
  • N-[3-[[4-(1-Methyl-1H-indole-3-yl)pyrimidine-2-yl]amino]-4-methoxy-6-[[2-(dimethylamino)ethyl](methyl)amino]phenyl]acrylamide
  • YY3